HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

about

Association of HER2 codon 655 polymorphism with ovarian cancer.Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis.Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.

P2860

Q40212670-EE5BB136-561E-4B07-9CF7-B58927AB83C5 Q51734194-D403627D-6EB6-4575-8AED-E28CE6975120 Q54111164-FEC23871-30C2-4489-9007-2C44788D2720

P2860

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

Item

http://www.wikidata.org/entity/Q36660906

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@ast

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@en

type

Item

label

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@ast

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@en

prefLabel

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@ast

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@en

P1476

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

@en

P2093

Abbas Ghaderi

http://www.w3.org/2001/XMLSchema#string

Alamtaj Samsami Dehaghani

http://www.w3.org/2001/XMLSchema#string

Mahyar Malekzadeh

http://www.w3.org/2001/XMLSchema#string

Mohammad Reza Haghshenas

http://www.w3.org/2001/XMLSchema#string

Nasroolah Erfani

http://www.w3.org/2001/XMLSchema#string

Zahra Mojtahedi

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

A simple salting out procedure for extracting DNA from human nucleated cells

A putative molecular-activation switch in the transmembrane domain of erbB2.

HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients.

HER2 targeted therapy in breast cancer...beyond Herceptin.

Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes.

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility was not credible: appraisal of a recent meta-analysis.

Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.

Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/IRCMJ.2173

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236043689

http://www.w3.org/2001/XMLSchema#string

P698

23487505

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

single-nucleotide polymorphism

P932

3589767

http://www.w3.org/2001/XMLSchema#string

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

about

P2860

P2860

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932